Literature DB >> 12217244

Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.

Chester V Oddis1.   

Abstract

Entities:  

Year:  2002        PMID： 12217244     DOI： 10.1007/s11926-002-0084-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  4 in total

1.  Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis.

Authors:  J Vencovský; K Jarosová; S Machácek; J Studýnková; J Kafková; J Bartůnková; D Nemcová; F Charvát
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

Review 2.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.

Authors:  F W Miller; L G Rider; Y L Chung; R Cooper; K Danko; V Farewell; I Lundberg; C Morrison; L Oakley; I Oakley; C Pilkington; J Vencovsky; K Vincent; D L Scott; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-11       Impact factor: 7.580

3.  Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.

Authors:  P Cherin; J C Piette; B Wechsler; O Bletry; J M Ziza; R Laraki; P Godeau; S Herson
Journal:  J Rheumatol       Date:  1994-06       Impact factor: 4.666

4.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.